Options for combination therapy of influenza and ARVI with combined drugs
https://doi.org/10.21518/2079-701X-2015-16-102-107
Abstract
According to the World Health Organization (WHO), 3 to 5 million cases of influenza are registered every year worldwide, of which 250--500 thousand are fatal. Epidemics of influenza and acute respiratory viral infections occur most often in winter, however, outbreaks may also be recorded in the autumn-winter and winter-spring periods. Sporadic cases of ARVI occur at any time of the year. Factors contributing to the development of flu epidemics include: high density of population in metropolitan areas; adverse environmental factors; inadequate immunization coverage; poor hygiene during epidemics; unhealthy eating habits (unbalanced, excessive). Groups at risk of severe and complicated course of influenza and ARVI are young children, the elderly, and patients suffering from chronic disorders of the upper respiratory tract, bronchopulmonary and cardiovascular systems, as well as people with immunodeficiency. [1]
Keywords
About the Authors
T. V. Sologub
Research Institute of Influenza, Ministry of Health of Russia, St. Petersburg
Russian Federation
Russian Federation
V. V. Tsvetkov
Research Institute of Influenza, Ministry of Health of Russia, St. Petersburg
Russian Federation
Russian Federation
G. S. Golobokov
Research Institute of Influenza, Ministry of Health of Russia, St. Petersburg
Russian Federation
Russian Federation
References
1. Haaheim EdL, Pattison J, Whitley R. A practical guide to clinical virology. John Wiley and Sons, 2001.
2. Bartlett YG. Pocket book of Infectious disease therapy. Wilkins and Williams, 1996.
3. Kelvin KW To, Alan KL Tsang, Jasper FW Chan, Vincent CC. Cheng, Honglin Chen, Kwok-Yung Yuen. Emergence in China of human disease due to avian influenza A(H10N8) e Cause for concern? Journal of Infection, 2014, 1/11:3.
4. Denholm JT, Gordon CL, Johnson PD et al. Hospitalised adult patients with pandemic (H1N1) 2009 influenza in Melbourne, Australia. MJA, 2010, 192(2): 84-86.
5. Fernandez-Sesma A, Marukian S, Ebersole BJ et al. Influenza Virus Evades Innate and Adaptive Immunity via the NS1 Protein. J. Virol, 2006, 80: 6295-6304.
6. Paulo Dornelles Picon et al. Symptomatic treatment of the common cold with a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: a randomized, placebo-controlled trial. BMC Infectious Diseases, 2013, 13: 556.
7. Zharkova NE. Symptomatic treatment of SARS: the future of the combination therapy. Russian Medical Journal, 2007, 22: 1636.
8. Bertin L et al. Randomised, double-blind, mul-ticenter, controlled trial of ibuprofen versus acetaminophen (paracetamol) and placebo for treatment of symptoms of tonsillitis and pharyngitis in children. Journal of Pediatrics, 1991, 119 (5): 811-4.
9. Bertin L et al. A randomised, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundam Clin Pharmacol, 1996, 10: 387-92.
10. De Clercq E. Antiviral agents active against influenza A viruses. Nat. Rev. Drug. Disc, 2006, 5: 1015-1021.
11. Кузин В.Б., Ловцова Л.В., Барсук АЛ. Исследование клинической эффективности и переносимости препарата Антигриппин-Максимум при лечении ОРВИ (гриппа). Справочник поликлинического врача, 2010, 1: 3-7.
12. Jefferson T, Demicheli V, Deeks JJ, Rivetti D. Amantadine and rimantadine for preventing and treating influenza A in adults (Cochrane Review) From The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd. All rights reserved.
13. Ивницкий Ю.Ю., Головко А.И., Софронов ГА. Янтарная кислота в системе средств метаболической коррекции функционального состояния и резистентности организма. Учебное пособие. Санкт-Петербург: ВМА, 1998. 82 с.
14. Зайцев А.А. Анализ комбинированных препаратов для лечения ОРВИ. Фарматека, 2009, 12: 77-82.
15. Andrade S, Martinez C, Walker A. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol, 1998, 51(12): 1357-1365.
Review
For citations:
Sologub TV, Tsvetkov VV, Golobokov GS. Options for combination therapy of influenza and ARVI with combined drugs. Meditsinskiy sovet = Medical Council. 2015;(16):102-107. (In Russ.) https://doi.org/10.21518/2079-701X-2015-16-102-107
Views:
541
Email this article 